Your browser doesn't support javascript.
loading
Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment.
Celli, Bartolome R; Navaie, Maryam; Xu, Zhun; Cho-Reyes, Soojin; Dembek, Carole; Gilmer, Todd P.
Affiliation
  • Celli BR; Chronic Obstructive Pulmonary Disease Center, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
  • Navaie M; Global Strategy, Advance Health Solutions, LLC, New York, NY, USA.
  • Xu Z; School of Professional Studies, Columbia University, New York, NY, USA.
  • Cho-Reyes S; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.
  • Dembek C; Global Strategy, Advance Health Solutions, LLC, New York, NY, USA.
  • Gilmer TP; Global Health Economics and Outcomes Research, Sunovion Pharmaceuticals Inc, Marlborough, MA, USA.
Int J Chron Obstruct Pulmon Dis ; 14: 1019-1031, 2019.
Article in En | MEDLINE | ID: mdl-31190787
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Practice Patterns, Physicians' / Bronchodilator Agents / Medicare / Pulmonary Disease, Chronic Obstructive / Medication Therapy Management / Adrenergic beta-2 Receptor Agonists / Formoterol Fumarate / Lung Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Int J Chron Obstruct Pulmon Dis Year: 2019 Document type: Article Affiliation country: United States Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Practice Patterns, Physicians' / Bronchodilator Agents / Medicare / Pulmonary Disease, Chronic Obstructive / Medication Therapy Management / Adrenergic beta-2 Receptor Agonists / Formoterol Fumarate / Lung Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Int J Chron Obstruct Pulmon Dis Year: 2019 Document type: Article Affiliation country: United States Country of publication: New Zealand